Learn More
Allan J. Collins, MD, Robert N. Foley, MB, Charles Herzog, MD, Blanche Chavers, MD, David Gilbertson, PhD, Areef Ishani, MD, MS, Bertram Kasiske, MD, Jiannong Liu, PhD, Lih-Wen Mau, PhD, Marshall McBean, MD, MSc, Anne Murray, MD, MSc, Wendy St. Peter, PharmD, Haifeng Guo, MS, Sally Gustafson, MS, Qi Li, MS, ShuLing Li, MS, Suying Li, PhD, Yi Peng, MS, Yang(More)
Knowledge of the excess risk posed by specific cardiovascular syndromes could help in the development of strategies to reduce premature mortality among patients with chronic kidney disease (CKD). The rates of atherosclerotic vascular disease, congestive heart failure, renal replacement therapy, and death were compared in a 5% sample of the United States(More)
BACKGROUND Little information is available regarding cardiac morbidity and mortality in children with end-stage renal disease. We sought to determine the incidence of cardiac morbidity and mortality in pediatric chronic dialysis patients. METHODS Medicare incident pediatric (0 to 19 years) dialysis patients from 1991 to 1996 were identified from the(More)
Come with us to read a new book that is coming recently. Yeah, this is a new coming book that many people really want to read will you be one of them? Of course, you should be. It will not make you feel so hard to enjoy your life. Even some people think that reading is a hard to do, you must be sure that you can do it. Hard will be felt when you have no(More)
BACKGROUND The extent of diabetes, chronic kidney disease (CKD), and cardiovascular disease (CVD) in the Medicare population is relatively unknown. Also unknown is the effect of these diseases on patient survival before end-stage renal disease (ESRD). METHODS Prevalent cohorts of Medicare enrollees from 1996 to 2000 were assessed for diabetes and CKD,(More)